Moorfields Eye Hospitals UAE are first in Dubai to successfully perform advanced glaucoma treatment utilising latest innovations in technology

Moorfields Eye Hospitals UAE are first in Dubai to successfully perform advanced glaucoma treatment utilising latest innovations in technology

Glaucoma affects a significant percentage of the population worldwide, and the risk increases with age. The non-surgical treatment options available for most patients are medications to reduce pressure in the eye and laser trabeculoplasty, which targets the drainage angle of the eye. However, for many patients with advanced glaucoma or complex secondary glaucoma, medications and laser treatments alone are not sufficient to control eye pressure and preserve vision. In these circumstances, aqueous tube shunts (also known as aqueous shunt devices or glaucoma drainage devices) have a much broader range of efficacy even in patients with the highest risk. The devices in common use are the Ahmed Valve and the Baerveldt Tube. The latest device however, is the PAUL implant, and the Glaucoma surgeons at Moorfields Eye Hospital Dubai were the first in Dubai to successfully perform several of these surgeries recently, for both children and adults. The PAUL implant is the latest generation of aqueous shunt devices. It has been designed to optimize efficacy with a higher safety profile. It is composed of a soft tube that is inserted into the eye and drains away excess fluid thereby controlling the eye pressure. The diameter of this tube is less than